ArticleAnnals of surgical oncology2024

ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer.

Nobuhiro Nakazawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.